AP1 Regulation of Proliferation and Initiation of Apoptosis in Erythropoietin-Dependent Erythroid Cells

REFERENCES

• Adachi, K., and H. Saito 1992. Induction of junB expression, but not c-jun, by granulocyte colony-stimulating factor or macrophage colony-stimulating factor in the proliferative response of human myeloid leukemia cells. J. Clin. Invest. 89: 1657–1661.
   PubMed Web of Science ®Google Scholar
• Adler, V., S. Y. Fuchs, J. Kim, A. Kraft, M. P. King, J. Pelling, and Z. Ronai 1995. Jun-NH2-terminal kinase activation mediated by UV-induced DNA lesions in melanoma and fibroblast cells. Cell Growth Differ. 6: 1437–1446.
   PubMedGoogle Scholar
• Alani, R., P. H. Brown, B. Binetruy, H. Dosaka, R. K. Rosenberg, P. Angel, M. Karin, and M. J. Birrer 1991. The transactivating function of the c-Jun proto-oncoprotein is required for cotransformation of rat embryo cells. Mol. Cell. Biol. 11: 6286–6295.
   PubMedGoogle Scholar
• Angel, P., E. A. Allegretto, S. T. Okino, K. Hattori, W. J. Boyle, T. Hunter, and M. Karin 1988. Oncogene jun encodes a sequence-specific trans-activator similar to AP-1. Nature 332: 166–171.
   PubMed Web of Science ®Google Scholar
• Angel, P., M. Imagawa, R. Chiu, B. Stein, R. J. Imbra, H. J. Rahmsdorf, C. Jonat, P. Herrlich, and M. Karin 1987. Phorbolester-inducible genes contain a common cis-element recognized by the TPA-modulated trans-acting factor. Cell 49: 729–739.
   PubMed Web of Science ®Google Scholar
• Assefa, Z., M. Garmyn, R. Bouillon, W. Merlevede, J. R. Vandenheede, and P. Agostinis 1997. Differential stimulation of ERK and JNK activities by ultraviolet B irradiation and epidermal growth factor in human keratinocytes. J. Invest. Dermatol. 108: 886–891.
   PubMed Web of Science ®Google Scholar
• Atfi, A., S. Djelloul, E. Chastre, R. R. Davis, and C. Gespach 1997. Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor β-mediated signaling. J. Biol. Chem. 272: 1429–1432.
   PubMed Web of Science ®Google Scholar
• Bossy-Wetzel, E., L. Bakiri, and M. Yaniv 1997. Induction of apoptosis by the transcription factor c-Jun. EMBO J. 16: 1695–1709.
   PubMed Web of Science ®Google Scholar
• Brown, P. H., R. Alani, L. H. Preis, E. Szabo, and M. J. Birrer 1993. Suppression of oncogene-induced transformation by a deletion mutant of c-jun. Oncogene 8: 877–886.
   PubMed Web of Science ®Google Scholar
• Brown, P. H., T. K. Chen, and M. J. Birrer 1994. Mechanism of action of a dominant-negative mutant of c-Jun. Oncogene 9: 791–799.
   PubMed Web of Science ®Google Scholar
• Butterfield, L., B. Storey, L. Maas, and L. E. Heasley 1997. c-Jun NH2-terminal kinase regulation of the apoptotic response of small cell lung cancer cells to ultraviolet radiation. J. Biol. Chem. 272: 10110–10116.
   PubMed Web of Science ®Google Scholar
• Chen, T. K., L. M. Smith, D. K. Gebhardt, M. J. Birrer, and P. H. Brown 1996. Activation and inhibition of the AP-1 complex in human breast cancer cells. Mol. Carcinog. 15: 215–226.
   PubMed Web of Science ®Google Scholar
• Chen, Y. R., C. F. Meyer, and T. H. Tan 1996. Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis. J. Biol. Chem. 271: 631–634.
   PubMed Web of Science ®Google Scholar
• Chin, H., N. Nakamura, R. Kamiyama, N. Miyasaka, J. N. Ihle, and O. Miura 1996. Physical and functional interactions between Stat5 and the tyrosine-phosphorylated receptors for erythropoietin and interleukin-3. Blood 88: 4415–4425.
   PubMed Web of Science ®Google Scholar
• Cohen, D. R., and T. Curran 1988. fra-1: a serum-inducible, cellular immediate-early gene that encodes a Fos-related antigen. Mol. Cell. Biol. 8: 2063–2069.
   PubMed Web of Science ®Google Scholar
• Curran, T., and N. M. Teich 1982. Candidate product of the FBJ murine osteosarcoma virus oncogene: characterization of a 55,000-dalton phosphoprotein. J. Virol. 42: 114–122.
   PubMedGoogle Scholar
• Damen, J. E., L. Liu, R. L. Cutler, and G. Krystal 1993. Erythropoietin stimulates the tyrosine phosphorylation of Shc and its association with Grb2 and a 145-Kd tyrosine phosphorylated protein. Blood 82: 2296–2303.
   PubMedGoogle Scholar
• Damen, J. E., A. L. Mui, J. L. Puil, T. Pawson, and G. Krystal 1993. Phosphatidylinositol 3-kinase associates, via its Src homology 2 domains, with the activated erythropoietin receptor. Blood 81: 3204–3210.
   PubMed Web of Science ®Google Scholar
• Damen, J. E., H. Wakao, A. Miyajima, J. Krosl, R. K. Humphries, R. L. Cutler, and G. Krystal 1995. Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. EMBO J. 14: 5557–5568.
   PubMed Web of Science ®Google Scholar
• Deng, T., and M. Karin 1993. JunB differs from c-Jun in its DNA-binding and dimerization domains, and represses c-Jun by formation of inactive heterodimers. Genes Dev. 7: 479–490.
   PubMed Web of Science ®Google Scholar
• Devemy, E., C. Billat, and B. Haye 1997. Activation of raf-1 and mitogen-activated protein kinases by erythropoietin and inositolphosphate-glycan in normal erythroid progenitor cells: involvement of protein kinase C. Cell. Signalling 9: 41–46.
   PubMedGoogle Scholar
• Domann, F. E., J. P. Levy, M. J. Birrer, and G. T. Bowden 1994. Stable expression of a c-JUN deletion mutant in two malignant mouse epidermal cell lines blocks tumor formation in nude mice. Cell Growth Differ. 5: 9–16.
   PubMedGoogle Scholar
• Dorsey, M. J., H. J. Tae, K. G. Sollenberger, N. T. Mascarenhas, L. M. Johansen, and E. J. Taparowsky 1995. B-ATF: a novel human bZIP protein that associates with members of the AP-1 transcription factor family. Oncogene 11: 2255–2265.
   PubMed Web of Science ®Google Scholar
• Foltz, I. N., and J. W. Schrader 1997. Activation of the stress-activated protein kinases by multiple hematopoietic growth factors with the exception of interleukin-4. Blood 89: 3092–3096.
   PubMedGoogle Scholar
• Francastel, C., R. Groisman, C. M. Pfarr, and J. Robert-Lezenes 1994. Antisense c-jun overcomes a differentiation block in a murine erythroleukemia cell line. Oncogene 9: 1957–1964.
   PubMedGoogle Scholar
• Franklin, C. C., V. Sanchez, F. Wagner, J. R. Woodgett, and A. S. Kraft 1992. Phorbol ester-induced amino-terminal phosphorylation of human JUN but not JUNB regulates transcriptional activation. Proc. Natl. Acad. Sci. USA 89: 7247–7251.
   PubMedGoogle Scholar
• Frey, R. S., and K. M. Mulder 1997. TGFbeta regulation of mitogen-activated protein kinases in human breast cancer cells. Cancer Lett. 117: 41–50.
   PubMedGoogle Scholar
• Gajate, C., M. T. Alonso, T. Schimmang, and F. Mollinedo 1996. C-Fos is not essential for apoptosis. Biochem. Biophys. Res. Commun. 218: 267–272.
   PubMed Web of Science ®Google Scholar
• He, T. C., N. Jiang, H. Zhuang, and D. M. Wojchowski 1995. Erythropoietin-induced recruitment of Shc via a receptor phosphotyrosine-independent, Jak2-associated pathway. J. Biol. Chem. 270: 11055–11061.
   PubMed Web of Science ®Google Scholar
• He, T. C., H. Zhuang, D. E. Quelle, and D. M. Wojchowski 1993. Association of the p85 regulatory subunit of phosphatidylinositol 3-kinase with an essential erythropoietin receptor subdomain. Blood 82: 3530–3538.
   PubMedGoogle Scholar
• Hirai, S. I., R. P. Ryseck, F. Mechta, R. Bravo, and M. Yaniv 1989. Characterization of Jun D: a new member of the jun oncogene family. EMBO J. 8: 1433–1439.
   PubMed Web of Science ®Google Scholar
• Hsu, J. C., D. E. Cressman, and R. Taub 1993. Promoter-specific trans-activation and inhibition mediated by JunB. Cancer Res. 53: 3789–3794.
   PubMedGoogle Scholar
• Jacobs-Helber, S. M., K. Penta, Z. H. Sun, A. Lawson, and S. T. Sawyer 1997. Distinct signaling from stem cell factor and erythropoietin in HCD57 cells. J. Biol. Chem. 272: 6850–6853.
   PubMed Web of Science ®Google Scholar
• Johnson, N. L., A. M. Gardner, K. M. Diener, C. A. Lange-Carter, J. Gleavy, M. B. Jarpe, A. Minden, M. Karin, L. I. Zon, and G. L. Johnson 1996. Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase kinase induce cell death. J. Biol. Chem. 271: 3229–3237.
   PubMed Web of Science ®Google Scholar
• Joneja, B., and D. M. Wojchowski 1997. Mitogenic signaling and inhibition of apoptosis via the erythropoietin receptor box-1 domain. J. Biol. Chem. 272: 11176–11184.
   PubMedGoogle Scholar
• Kallunki, T., T. Deng, M. Hibi, and M. Karin 1996. c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. Cell 87: 929–939.
   PubMedGoogle Scholar
• Kang, L. Y., and Y. C. Yang 1995. Activation of junB and c-myc primary response genes by interleukin 9 in a human factor-dependent cell line. J. Cell. Physiol. 163: 623–630.
   PubMedGoogle Scholar
• Karin, M., Z. G. Liu, and E. Zandi 1997. AP-1 function and regulation. Curr. Opin. Cell Biol. 9: 240–246.
   PubMed Web of Science ®Google Scholar
• Kelley, L. L., M. J. Koury, M. C. Bondurant, S. T. Koury, S. T. Sawyer, and A. Wickrema 1993. Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: a mechanism for controlled rates of erythrocyte production. Blood 82: 2340–2352.
   PubMedGoogle Scholar
• Klingmüller, U., H. Wu, J. G. Hsiao, A. Toker, B. C. Duckworth, L. C. Cantley, and H. F. Lodish 1997. Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. Proc. Natl. Acad. Sci. USA 94: 3016–3021.
   PubMed Web of Science ®Google Scholar
• Koury, M. J., and M. C. Bondurant 1992. The molecular mechanism of erythropoietin action. Eur. J. Biochem. 210: 649–663.
   PubMedGoogle Scholar
• Lacronique, V., P. Varlet, P. Mayeux, A. Porteau, S. Gisselbrecht, A. Kahn, and C. Lacombe 1997. Bcl-2 targeted overexpression into the erythroid lineage of transgenic mice delays but does not prevent the apoptosis of erythropoietin-deprived erythroid progenitors. Blood 90: 3050–3056.
   PubMed Web of Science ®Google Scholar
• Latinis, K. M., and G. A. Koretzky 1996. Fas ligation induces apoptosis and Jun kinase activation independently of CD45 and Lck in human T cells. Blood 87: 871–875.
   PubMed Web of Science ®Google Scholar
• Maniatis, T., E. F. Fritsch, and J. Sambrook 1989. Molecular cloning: a laboratory manual2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
   Google Scholar
• Miura, O., Y. Miura, N. Nakamura, F. W. Quelle, B. A. Witthuhn, J. N. Ihle, and N. Aoki 1994. Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor. Blood 84: 4135–4141.
   PubMed Web of Science ®Google Scholar
• Miura, Y., O. Miura, J. N. Ihle, and N. Aoki 1994. Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor. J. Biol. Chem. 269: 29962–29969.
   PubMedGoogle Scholar
• Nagata, Y., E. Nishida, and K. Todokoro 1997. Activation of JNK signaling pathway by erythropoietin, thrombopoietin, and interleukin-3. Blood 89: 2664–2669.
   PubMed Web of Science ®Google Scholar
• Nishina, H., H. Sato, T. Suzuki, M. Sato, and H. Iba 1990. Isolation and characterization of fra-2, an additional member of the fos gene family. Proc. Natl. Acad. Sci. USA 87: 3619–3623.
   PubMedGoogle Scholar
• Okamoto, K., K. Fujisawa, T. Hasunuma, T. Kobata, T. Sumida, and K. Nishioka 1997. Selective activation of the JNK/AP-1 pathway in FAS-mediated apoptosis of rheumatoid arthritis synoviocytes. Arthritis Rheum. 40: 919–926.
   PubMedGoogle Scholar
• Patel, H. R., and A. J. Sytkowski 1995. Erythropoietin activation of AP1 (Fos/Jun). Exp. Hematol. 23: 619–625.
   PubMedGoogle Scholar
• Payne, C. M., C. Bernstein, and H. Bernstein 1995. Apoptosis overview emphasizing the role of oxidative stress, DNA damage and signal-transduction pathways. Leuk. Lymphoma 19: 43–93.
   PubMed Web of Science ®Google Scholar
• Penta, K., and S. T. Sawyer 1995. Erythropoietin induces the tyrosine phosphorylation, nuclear translocation, and DNA binding of STAT1 and STAT5 in erythroid cells. J. Biol. Chem. 270: 31282–31287.
   PubMed Web of Science ®Google Scholar
• Roffler-Tarlov, S., J. J. Brown, E. Tarlov, J. Stolarov, D. L. Chapman, M. Alexiou, and V. E. Papaioannou 1996. Programmed cell death in the absence of c-Fos and c-Jun. Development 122: 1–9.
   PubMedGoogle Scholar
• Ryder, K., A. Lanahan, E. Perez-Albuerne, and D. Nathans 1988. Jun-D: a third member of the Jun family. Proc. Natl. Acad. Sci. USA 86: 1500–1503.
   Google Scholar
• Sawyer, S. T., and K. Penta 1994. Erythropoietin cell biology. Hematol. Oncol. Clin. N. Am. 8: 895–911.
   PubMedGoogle Scholar
• Sawyer, S. T., and K. Penta 1996. Association of JAK2 and STAT5 with erythropoietin receptors—role of receptor phosphorylation in erythropoietin signal transduction. J. Biol. Chem. 271: 32430–32437.
   PubMedGoogle Scholar
• Schlingensiepen, R., H. Terlau, W. Brysch, and K. H. Schlingensiepen 1994. Differential expression of c-jun, junB and junD in rat hippocampal slices. Neuroreport 6: 101–104.
   PubMedGoogle Scholar
• Schutte, J., J. D. Minna, and M. J. Birrer 1989. Deregulated expression of human c-jun transforms primary rat embryo cells in cooperation with an activated c-Ha-ras gene and transforms Rat-1a cells as a single gene. Proc. Natl. Acad. Sci. USA 86: 2257–2261.
   PubMed Web of Science ®Google Scholar
• Silva, M., D. Grillot, A. Benito, C. Richard, G. Nunez, and J. L. Fernandez-Luna 1996. Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through BclXL and Bcl-2. Blood 88: 1576–1582.
   PubMed Web of Science ®Google Scholar
• Tauchi, T., G. S. Feng, R. Shen, M. Hoatlin, G. Bagby, D. Kabat, L. Lu, and H. E. Broxmeyer 1995. Involvement of SH2-containing phosphotyrosine phosphatase Syp in erythropoietin receptor signal transduction pathways. J. Biol. Chem. 270: 5631–5635.
   PubMed Web of Science ®Google Scholar
• Tauchi, T., K. Toyama, G. S. Feng, H. E. Broxmeyer, and G. Krystal 1996. Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis. Blood 87: 4495–4501.
   PubMed Web of Science ®Google Scholar
• Terada, K., Y. Kaziro, and T. Satoh 1997. Ras-dependent activation of c-Jun N-terminal kinase/stress-activated protein kinase in response to interleukin-3 stimulation in hematopoietic BaF3 cells. J. Biol. Chem. 272: 4544–4548.
   PubMedGoogle Scholar
• Testolin, L., C. Carson, Y. Z. Wang, P. R. Walker, U. Armato, and M. Sikorska 1997. Jun and JNK kinase are activated in thymocytes in response to VM26 and radiation but not glucocorticoids. Exp. Cell Res. 230: 220–232.
   PubMedGoogle Scholar
• Thomas, P. S. 1980. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc. Natl. Acad. Sci. USA 77: 5201–5205.
   PubMed Web of Science ®Google Scholar
• Todokoro, K., M. Sugiyama, E. Nishida, and K. Nakaya 1994. Activation of mitogen-activated protein kinase cascade through erythropoietin receptor. Biochem. Biophys. Res. Commun. 203: 1912–1919.
   PubMedGoogle Scholar
• Verheij, M., R. Bose, X. H. Lin, B. Yao, W. D. Jarvis, S. Grant, M. J. Birrer, E. Szabo, L. I. Zon, and J. M. Kyriakis 1996. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380: 75–79.
   PubMed Web of Science ®Google Scholar
• Wakao, H., F. Gouilleux, and B. Groner 1995. Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J. 14: 854–855.
   PubMedGoogle Scholar
• Wickrema, A., S. B. Krantz, J. C. Winkelmann, and M. C. Bondurant 1992. Differentiation and erythropoietin receptor gene expression in human erythroid progenitor cells. Blood 80: 1940–1949.
   PubMed Web of Science ®Google Scholar
• Witthuhn, B. A., F. W. Quelle, O. Silvennoinen, T. Yi, B. Tang, O. Miura, and J. N. Ihle 1993. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74: 227–236.
   PubMed Web of Science ®Google Scholar
• Xia, Z., M. Dickens, J. Raingeaud, R. J. Davis, and M. E. Greenberg 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326–1331.
   PubMed Web of Science ®Google Scholar
• Zerial, M., L. Toschi, R. P. Ryseck, M. Schuermann, R. Muller, and R. Bravo 1989. The product of a novel growth factor activated gene, fos-B, interacts with Jun proteins enhancing their DNA binding activity. EMBO J. 8: 805–815.
   PubMed Web of Science ®Google Scholar
• Zhao, B. H., W. P. Yu, M. Qian, M. Simmons-Menchaca, P. H. Brown, M. J. Birrer, B. G. Sanders, and K. Kline 1997. Involvement of activator protein-1 (AP-1) in induction of apoptosis by vitamin E succinate in human breast cancer cells. Mol. Carcinog. 19: 180–190.
   PubMed Web of Science ®Google Scholar
• Zhuang, H., Z. Niu, T.-C. He, S. V. Patel, and D. M. Wojchowski 1995. Erythropoietin-dependent inhibition of apoptosis is supported by carboxyl-truncated receptor forms and blocked by dominant-negative forms of Jak2. J. Biol. Chem. 270: 14500–14504.
   PubMed Web of Science ®Google Scholar
• Zhuang, H., S. V. Patel, T. C. He, Z. Niu, and D. M. Wojchowski 1994. Dominant negative effects of a carboxy-truncated Jak2 mutant on Epo-induced proliferation and Jak2 activation. Biochem. Biophys. Res. Commun. 204: 278–283.
   PubMedGoogle Scholar